GleamWall
中文EN

EYPT EyePoint, Inc.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1314102 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-93.9%
TTM net income YoY-66.5%
TTM EPS YoY-32.3%
Revenue 3-yr CAGR-60.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-13,642.0%
Net margin-13,281.2%
FCF margin-11,599.4%
EBITDA margin-13,533.9%

Returns

ROE-221.9%
ROA-164.0%
ROIC (approx.)-368.4%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets34.7%
Debt / equity0.00x
Current ratio3.30x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.86x
Accruals ratio-22.9%
Payout ratio—
Capex / revenue170.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$31.37M$43.27M
R&D expense$221.04M$132.93M
SG&A expense$51.61M$52.36M
Operating income-$243.43M-$145.85M
Interest expense$33,000$14,000
Pretax income-$231.68M-$130.78M
Income tax$279,000$90,000
Net income-$231.96M-$130.87M
EBITDA-$241.12M-$144.31M
EPS (basic)-3.17-2.32
EPS (diluted)-3.17-2.32
Weighted avg. shares (diluted)73,25156,298
Balance sheet
Cash & equivalents$101.82M$99.85M
Short-term investments$204.26M$271.21M
Inventory$1.81M$2.31M
Current assets$328.65M$383.31M
PP&E, net$9.02M$8.18M
Total assets$364.00M$418.46M
Current liabilities$37.02M$49.05M
Total liabilities$57.88M$81.96M
Shareholders' equity$306.11M$336.50M
Shares outstanding82.83M68.27M
Cash flow statement
Operating cash flow-$240.11M-$126.23M
Capital expenditure$3.28M$4.05M
Free cash flow-$243.39M-$130.28M
Investing cash flow$68.58M-$219.35M
Financing cash flow$173.65M$164.02M
Depreciation & amortization$2.31M$1.54M
Stock-based compensation$27.87M$36.74M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.